With revenue up 9%, why does the NIB share price keep falling?

Will the ailing share price make a full recovery?

| More on:
Stethoscope with a piggy bank in the middle.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NIB Holdings Limited (ASX: NHF) share price has suffered a very unhealthy decline of 27% in the past 12 months. That's despite the S&P/ASX 200 Index (ASX: XJO) rising roughly 12%, meaning the ASX healthcare share has underperformed by close to a whopping 40%.

Created with Highcharts 11.4.3NIB Holdings PriceZoom1M3M6MYTD1Y5Y10YALL12 Feb 202412 Feb 2025Zoom ▾Mar '24May '24Jul '24Sep '24Nov '24Jan '25Apr '24Apr '24Jul '24Jul '24Oct '24Oct '24Jan '25Jan '25www.fool.com.au

The decline has also happened despite NIB still growing in scale during this period, so it begs the question of what's going on and whether this is an opportunity. It grew its revenue by 9% in FY24.

It's normal for there to be difficulties for specific industries sometimes. Private health insurance is a niche industry compared to general insurance, in my view, with more complexity due to private hospitals and government funding involvement.

What's going on in the private health industry?

Operators like NIB and Medibank Private Ltd (ASX: MPL) are partly dependent on the overall health of the private system.

Investment bank Goldman Sachs thinks industry policyholder growth has remained "resilient" through the first half of FY25 ("perhaps surprising to the upside", in the broker's words), though it notes weakening affordability for Australians. This may be a key driver of the NIB share price, in my view.

Goldman Sachs also suggested that the "competitive environment for policyholder acquisition is still strong resulting in lapses / churn reverting toward pre-COVID levels".

Policyholder growth has been supported by factors like population growth, first-time take-ups of private health insurance, and younger age groups, according to Goldman Sachs.

The industry has been under pressure to keep a lid on premium increases to help affordability and reduce inflation. However, Goldman Sachs believes the April 2025 approved premium rate increases could be higher than 2024 because of "hospital indexation/inflation (including nurse wages) as well as higher bed rates for private patients in NSW public hospitals."

The broker is concerned that the risks for the profit margins of NIB (and Medibank) "are building with inflationary pressures and low approved premium rate increases". NIB is expecting to achieve net margins within its target net margin range of between 6% and 7%.

Is the NIB share price attractive?

The group underlying operating profit (UOP) guidance from NIB is $235 million to $250 million, with Goldman Sachs thinking NIB will be at the bottom end of that range.

Overall, for the FY25 first-half result, the broker expects NIB to achieve insurance revenue of $1.71 billion, an insurance operating profit of $93.6 million, and an underlying operating profit of $101.4 million. The forecast FY25 half-year dividend is 11.1 cents per share.

For the full FY25 result, Goldman Sachs projects $3.7 billion of revenue, $216.7 million of insurance operating profit, and $236.5 million of underlying operating profit, with a possible annual dividend per share of 26.5 cents.

At the current NIB share price, it's valued at 15x FY25's estimated earnings with a possible grossed-up dividend yield, including franking credits.

If investors are interested in NIB shares, then I'd say this is the right time to look at the company. Goldman Sachs currently has a buy rating on NIB shares with a price target of $6.50, implying a possible 12-month rise of just over 10% from where it is today.

Should you invest $1,000 in Computershare Limited right now?

Before you buy Computershare Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Computershare Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Guess which ASX 300 stock is jumping 11% on big news

This stock is having a day to remember on Thursday. But why?

Read more »

A group of medical researchers stands side by side with each other wearing white coats in their research laboratory with scientific equipment in the background.
Healthcare Shares

Trump executive order to hit these 3 ASX pharmaceutical stocks

Donald Trump’s new executive order caused these 3 ASX pharmaceutical stocks to crash on Monday.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Healthcare Shares

Guess which ASX 200 stock is jumping 16% on big news

Let's find out what news is getting investors excited this afternoon.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Healthcare Shares

Why is this ASX 300 stock crashing 18% today?

Investors are rushing to the exits. But why? Let's look into things.

Read more »

Health professional working on his laptop.
Healthcare Shares

Are CSL shares at risk from the Trump tariffs?

How exposed are CSL shares to potential Trump medicinal tariffs?

Read more »

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Healthcare Shares

What did CSL have to say at Macquarie's 2025 conference?

Does this business have a healthy growth outlook?

Read more »

smiling health care workers in a medical setting
Healthcare Shares

Sonic Healthcare shares are down more than 40% since 2021. Will its AI initiative be the catalyst for a turnaround?

Could AI spark a recovery for this ASX healthcare stock?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Why is this ASX All Ords stock jumping 7% today?

This stock is ending the week strongly. Let's find out what is getting investors excited.

Read more »